Robert Lustig: In children, aspirin can cause Reye syndrome, leading to deadly fatty liver disease

Dear Subscriber,
Thank you for watching our channel. In this series of shorts, we've selected some key soundbites from Professor Robert Lustig's convdersation with Neeku Mahdavian of Emery Pharma.
In the podcast hosted by Emery Pharma, Dr. Robert Lustig discusses the dangers of ultra-processed foods, arguing that they are not true food but toxins. He emphasizes that calories from different sources are not equivalent, explaining that the body's response to calories varies depending on the food's composition, such as fiber, protein, fats, and sugars. Lustig criticizes the focus on calorie counting, especially concerning sugary drinks, and explains how fructose, unlike glucose, is particularly harmful due to its metabolism in the liver, leading to fat production and mitochondrial dysfunction. He highlights the importance of whole foods and the negative impact of high fructose corn syrup and other sweeteners on health, particularly in causing obesity and other metabolic diseases. Lustig also stresses that while exercise is beneficial, it cannot fully counteract the negative effects of a poor diet rich in ultra-processed foods. The discussion concludes with a call to avoid ultra-processed foods and focus on a diet consisting of real, whole foods for better health and longevity.
we also recommend watching the entire collection of Professor Lustig presentation here:

About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.

Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.

Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.